Morgan Stanley Institutional Investment Advisors LLC Buys Shares of 77,934 National Health Investors, Inc. $NHI

Morgan Stanley Institutional Investment Advisors LLC purchased a new stake in National Health Investors, Inc. (NYSE:NHI) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 77,934 shares of the real estate investment trust’s stock, valued at approximately $5,943,000. National Health Investors accounts for about 0.6% of Morgan Stanley Institutional Investment Advisors LLC’s investment portfolio, making the stock its 5th biggest holding.

A number of other institutional investors also recently modified their holdings of NHI. NewEdge Advisors LLC boosted its stake in National Health Investors by 28.7% in the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust’s stock valued at $114,000 after buying an additional 345 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in National Health Investors by 9.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 249,937 shares of the real estate investment trust’s stock valued at $18,460,000 after acquiring an additional 21,851 shares during the last quarter. Jane Street Group LLC raised its stake in National Health Investors by 1,728.4% during the first quarter. Jane Street Group LLC now owns 69,697 shares of the real estate investment trust’s stock worth $5,148,000 after acquiring an additional 65,885 shares in the last quarter. Cetera Investment Advisers raised its stake in National Health Investors by 6.1% during the second quarter. Cetera Investment Advisers now owns 4,792 shares of the real estate investment trust’s stock worth $336,000 after acquiring an additional 275 shares in the last quarter. Finally, American Century Companies Inc. lifted its holdings in shares of National Health Investors by 2.2% in the second quarter. American Century Companies Inc. now owns 19,236 shares of the real estate investment trust’s stock worth $1,349,000 after acquiring an additional 420 shares during the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on NHI shares. Deutsche Bank Aktiengesellschaft reduced their price target on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a research note on Thursday, June 25th. Wells Fargo & Company lowered their price objective on shares of National Health Investors from $84.00 to $79.00 and set an “equal weight” rating for the company in a research report on Monday, June 1st. Zacks Research downgraded shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research note on Thursday, June 25th. BMO Capital Markets cut their target price on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating on the stock in a research report on Monday, June 15th. Finally, Weiss Ratings lowered shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, June 12th. Five equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $83.86.

National Health Investors Price Performance

Shares of NHI opened at $73.59 on Monday. National Health Investors, Inc. has a 12-month low of $67.94 and a 12-month high of $91.38. The business has a 50-day simple moving average of $75.48 and a two-hundred day simple moving average of $79.09. The company has a quick ratio of 6.78, a current ratio of 6.78 and a debt-to-equity ratio of 0.81. The stock has a market cap of $3.61 billion, a PE ratio of 21.27, a PEG ratio of 3.36 and a beta of 0.51.

National Health Investors (NYSE:NHI) last posted its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The firm had revenue of $121.32 million during the quarter. During the same quarter in the prior year, the business posted $1.22 earnings per share. National Health Investors’s revenue for the quarter was up 1.6% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Analysts anticipate that National Health Investors, Inc. will post 4.78 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be paid a $0.92 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.68 annualized dividend and a dividend yield of 5.0%. National Health Investors’s dividend payout ratio is currently 108.67%.

Insider Buying and Selling

In other National Health Investors news, Director Robert A. Mccabe, Jr. bought 890 shares of National Health Investors stock in a transaction on Monday, June 15th. The shares were purchased at an average cost of $71.65 per share, with a total value of $63,768.50. Following the acquisition, the director directly owned 44,159 shares of the company’s stock, valued at $3,163,992.35. The trade was a 2.06% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO D. Eric Mendelsohn bought 1,500 shares of National Health Investors stock in a transaction on Friday, June 5th. The shares were acquired at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the acquisition, the chief executive officer directly owned 133,316 shares in the company, valued at approximately $9,177,473.44. The trade was a 1.14% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 2.70% of the stock is owned by company insiders.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.